» Articles » PMID: 25706122

Lipidomic Profiling of Di- and Tri-acylglycerol Species in Weight-controlled Mice

Overview
Journal PLoS One
Date 2015 Feb 24
PMID 25706122
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Weight control by dietary calorie restriction (DCR) or exercise has been shown to prevent cancer in various models. However, the mechanisms as to how weight control is beneficial are not well understood. While previous reports have investigated the effects of weight control on total lipid levels or lipid composition within cellular membranes, there has been little work surrounding changes to individual lipids following weight control interventions. In this study, using a model of skin carcinogenesis centered on the tumor promotion stage, CD-1 mice were randomly assigned into 4 groups: ad libitum and sedentary (control), ad libitum with exercise (AL+Exe), exercise with pair feeding of a diet isocaloric with control (PF+Exe), and sedentary with 20% DCR compared to control. After ten weeks, body weight and body fat percentages significantly decreased in the PF+Exe and DCR groups but not AL+Exe when compared with sedentary controls. Murine skin and plasma samples were obtained for analysis. Lipidomics using electrospray ionization MS/MS was employed to profile triacylglycerol (TG) and diacylglycerol (DG) species. Both plasma and tissue TG species containing fatty acid chains with length 18:1 were significantly decreased following DCR when compared to sedentary control animals. In regards to DG, the most significant changes occurred in the plasma. DG species containing fatty acids with lengths 16:1 or 18:1 were significantly decreased in PF+Exe and DCR groups when compared to sedentary controls. Due to the significant role of TG in energy storage and DG in cellular signaling, our findings of the effects of weight control on individual TG and DG species in plasma and skin tissue following exposure to a tumor promoter, may provide insight into the mechanism of weight control on cancer prevention.

Citing Articles

Skin Metabolic Signatures of Psoriasis and Psoriasis Concurrent with Metabolic Syndrome.

Yan L, Wang W, Dong M, Wang R, Li C J Inflamm Res. 2025; 18():505-517.

PMID: 39810975 PMC: 11730757. DOI: 10.2147/JIR.S493338.


Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variant.

Faccioli L, Faccioli L, Sun Y, Animasahun O, Motomura T, Liu Z Hepatology. 2024; .

PMID: 39190693 PMC: 11865362. DOI: 10.1097/HEP.0000000000001065.


Interep: An R Package for High-Dimensional Interaction Analysis of the Repeated Measurement Data.

Zhou F, Ren J, Liu Y, Li X, Wang W, Wu C Genes (Basel). 2022; 13(3).

PMID: 35328097 PMC: 8950762. DOI: 10.3390/genes13030544.


Gene-Environment Interaction: A Variable Selection Perspective.

Zhou F, Ren J, Lu X, Ma S, Wu C Methods Mol Biol. 2021; 2212:191-223.

PMID: 33733358 DOI: 10.1007/978-1-0716-0947-7_13.


Penalized Variable Selection for Lipid-Environment Interactions in a Longitudinal Lipidomics Study.

Zhou F, Ren J, Li G, Jiang Y, Li X, Wang W Genes (Basel). 2019; 10(12).

PMID: 31816972 PMC: 6947406. DOI: 10.3390/genes10121002.


References
1.
Takai Y, Sasaki T, Matozaki T . Small GTP-binding proteins. Physiol Rev. 2001; 81(1):153-208. DOI: 10.1152/physrev.2001.81.1.153. View

2.
Speakman J, Mitchell S . Caloric restriction. Mol Aspects Med. 2011; 32(3):159-221. DOI: 10.1016/j.mam.2011.07.001. View

3.
Torrecillas A, Corbalan-Garcia S, de Godos A, Gomez-Fernandez J . Activation of protein kinase C alpha by lipid mixtures containing different proportions of diacylglycerols. Biochemistry. 2001; 40(49):15038-46. DOI: 10.1021/bi015599+. View

4.
Pamplona R, Barja G, Portero-Otin M . Membrane fatty acid unsaturation, protection against oxidative stress, and maximum life span: a homeoviscous-longevity adaptation?. Ann N Y Acad Sci. 2002; 959:475-90. DOI: 10.1111/j.1749-6632.2002.tb02118.x. View

5.
Vainio H, Kaaks R, Bianchini F . Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev. 2003; 11 Suppl 2:S94-100. View